| Financial Year |
March 31 2023 |
| Monetary Funds |
131,213,788.60 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
31,195,122.10 |
| Advances to Suppliers |
10,785,814.78 |
| Other Receivables |
49,845,859.86 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
782,878,192.53 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,952,310.79 |
| Total Current Assets |
1,017,688,653.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
596,450,224.98 |
| Long-term Equity Investment |
166,309,708.20 |
| Investment Properties |
222,985,279.35 |
| Fixed Assetes |
79,331,468.93 |
| Under-construction Projects |
988,719.47 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
214,608,697.59 |
| R&D expenses |
-- |
| Goodwill |
12,502,050.93 |
| Long-Term Deferred and Prepaid Expenses |
2,374,526.06 |
| Deferred Income Tax Assets |
122,325,602.79 |
| Other Non-Current Assets |
265,733.31 |
| Sub-Total of Non-Current Assets |
1,578,125,479.26 |
| Total Assets |
2,595,814,132.78 |
| Short-Term Loans |
235,293,750.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
34,673,057.19 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,085,994.06 |
| Taxes Payable |
193,014,288.04 |
| Interest Payable |
-- |
| Dividend Payable |
17,331.40 |
| Other payables |
170,003,748.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,015,259.73 |
| Other Current Liabilities |
1,820,427.90 |
| Sub-Total of Current Liabilities |
656,865,754.78 |
| Long-term Loans |
149,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
53,284,772.16 |
| Special Payable |
-- |
| Estimatied Liabilities |
65,960,418.64 |
| Deferred Income Tax Liabilities |
8,278,567.75 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
286,129,490.10 |
| Total Liabilities |
942,995,244.88 |
| Paid-In Capital(Or Share Stock) |
638,280,604.00 |
| Capital Surplus |
541,157,844.74 |
| Surplus Reserve |
250,422,973.13 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
232,344,885.98 |
| Minority Stockholder's Interest |
-10,608,496.78 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,663,427,384.68 |
| Owner's Equity（Stockholder's Equity） |
1,652,818,887.90 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,595,814,132.78 |
